文献速递鼻科

内镜鼻窦手术后局部布地奈德使用趋势的变化

Evolving Utilization of Topical Budesonide Following Endoscopic Sinus Surgery.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-04-23

该研究分析了2016至2022年本医疗系统内8157例内镜鼻窦手术(ESS)患者的术后处方数据,发现术后30天和180天内局部布地奈德处方率分别为15.9%和22.1%,且处方频率逐年显著增加,2022年达20.3%和24.9%;同期术后口服糖皮质激素(OCS)处方频率下降(P < .001)。作者认为局部布地奈德冲洗在ESS后日益常用,可能减少术后OCS需求,主张将其纳入ESS术后处方集覆盖范围。

要点

  • 8157例ESS患者中,术后30天和180天内局部布地奈德处方率分别为15.9%和22.1%。
  • 布地奈德处方频率逐年显著增加,2022年术后30天和180天处方率分别为20.3%和24.9%。
  • 同期术后口服糖皮质激素处方频率下降(P < .001)。

核心结论

  • 局部布地奈德冲洗在ESS后处方日益频繁,可能减少术后OCS需求,作者主张将其纳入ESS术后处方集覆盖范围。

研究设计与样本

  • 提取并分析2016至2022年本医疗系统内接受ESS患者的术后处方数据。
  • 共纳入8157例ESS患者。

主要发现

  • 8157例ESS患者中,术后30天内15.9%、术后180天内22.1%接受了局部布地奈德处方。
  • 布地奈德处方频率逐年显著增加,2022年术后30天和180天处方率分别达20.3%和24.9%。
  • 同期术后口服糖皮质激素处方频率呈下降趋势(P < .001)。

临床怎么用

  • 作者认为局部布地奈德冲洗在ESS后日益常用,可能减少术后OCS需求,并主张将其纳入ESS术后处方集覆盖范围。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Topical budesonide irrigations are frequently prescribed after endoscopic sinus surgery (ESS) to manage mucosal inflammation. However, this off-label indication may conflict with health insurance formularies. We sought to quantify the relative frequency of postoperative budesonide prescriptions to determine if this could be considered common practice after ESS. We extracted and analyzed postoperative prescription data for patients undergoing ESS from 2016 to 2022 within our health care system. Overall, among 8157 ESS patients, 15.9% and 22.1% received topical budesonide prescriptions within 30 or 180 days postoperatively, respectively. On a year-over-year basis, budesonide prescription frequency increased significantly over time, culminating at 20.3% and 24.9% in 2022. Conversely, postoperative oral corticosteroid (OCS) prescriptions showed a decreasing frequency over the same time period (P < .001). Our results show topical budesonide irrigations are increasingly frequently prescribed after ESS and may offset postoperative OCS requirements. This argues for coverage of topical budesonide as a formulary medication after ESS.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Mitchell MB, Bhattacharyya N. Evolving Utilization of Topical Budesonide Following Endoscopic Sinus Surgery. Otolaryngol Head Neck Surg. 2024. PMID: 38651615. doi:10.1002/ohn.788

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。